| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157782 killing or inhibiting the multiplication of tumor cells or cancer cells or as an immunosuppresant |
| 08/12/2004 | US20040157781 Peptide binding the KLVFF-sequence of amyloid-beta |
| 08/12/2004 | US20040157780 Epitopes on a number of immunogenic target proteins can be identified using the peptides; antigens include prostate cancer specific antigen (PSA), hepatitis B core and surface antigens (HBVc, HBVs) hepatitis C antigens, Epstein-Barr virus antigens |
| 08/12/2004 | US20040157779 Prevention and treatment of amyloidogenic disease |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157777 peptides that bind to the Y2 receptor when administered peripherally to a mammal induce weight loss |
| 08/12/2004 | US20040157776 Method of treating inflammation in the joints of a body |
| 08/12/2004 | US20040157775 Effector proteins of rapamycin |
| 08/12/2004 | US20040157772 Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis |
| 08/12/2004 | US20040157770 anti-cancer agents; |
| 08/12/2004 | US20040157769 Stabilized pharmaceutical composition in lyophilized form |
| 08/12/2004 | US20040157768 Cyclosporins for the treatment of immune disorders |
| 08/12/2004 | US20040157767 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/12/2004 | US20040157330 Compositions and methods for targeted biological delivery of molecular carriers |
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157327 Pablo, a polypeptide that interacts with BCL-XL, and uses related thereto |
| 08/12/2004 | US20040157326 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors |
| 08/12/2004 | US20040157314 Inhibitors of Staphylococcus aureus primary sigma factor and uses thereof |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157309 for treating respiratory disorders; for producing a catalytic domain of a zinc metalloprotease; genetic engineering |
| 08/12/2004 | US20040157308 Alpha-galactosidase as food-grade genetic marker |
| 08/12/2004 | US20040157306 Mammalian protein phosphatases |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157299 by transducing the tumor cells with a herpes simplex virus amplicon containing the gene for an immunomodulating protein; for multi-transduced cells for multi-targeted therapy; genetic engineering |
| 08/12/2004 | US20040157298 capable of being crystallized without being complexed to a ligand molecule; human growth hormone receptor (hGHR); for drug design |
| 08/12/2004 | US20040157297 for drug screening anticancer agents using animal models; biochips; genetic engineering |
| 08/12/2004 | US20040157296 Canine and feline B7-2 proteins, compositions and uses thereof |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157264 Piperazine melanocortin-specific compounds |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157246 Purified protein encoded by a nucleic acid hybridizable to a DNA of given sequence; use in diagnosis, prognosis and screening for a disposition to cardiovascular disorders |
| 08/12/2004 | US20040157241 Haemophilus adherence and penetration proteins |
| 08/12/2004 | US20040157239 Endonuclease capable of cleaving DNA from divalent cations, which retains its activity in acidic to neutral pH range, and is not inhibited by G-actin; treatment of cystic fibrosis |
| 08/12/2004 | US20040157234 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42 |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157225 pharmaceuticals, kits and recombinant animal models for prognosis/prevention |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157221 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 08/12/2004 | US20040157216 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 08/12/2004 | US20040156922 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators |
| 08/12/2004 | US20040156921 inhibiting the growth of endothelial cells and vascularization, including treating rheumatoid, psoriatic and osteoarthritis; screening for a therapeutic agent angiogenesis inhibitors; optionally antiangiogenic, antitumor or immunostimulants |
| 08/12/2004 | US20040156914 Slow release protein polymers |
| 08/12/2004 | US20040156865 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
| 08/12/2004 | US20040156861 elicit native epitope-reactive Cm; may contribute to the development of CTL-epitope based vaccines in viral disease and cancer. |
| 08/12/2004 | US20040156851 high mobility group box A box that can inhibit release of a proinflammatory cytokine and an agent that inhibits TNF biological activity that is infliximab, etanercept, adalimumab, CDP870, CDP571, Lenercept, or Thalidomide, |
| 08/12/2004 | US20040156850 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 08/12/2004 | US20040156848 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 08/12/2004 | US20040156843 peptides containing specific amino acid sequences or antibodies that bind to cell membrane antigens on the surface of rapidly dividing endothelial cells; polynucleotide molecule encoding a heavy chain variable domain of antibody B2G4, |
| 08/12/2004 | US20040156842 Uses of human Zven antagonists |
| 08/12/2004 | US20040156841 Human amine transporter |
| 08/12/2004 | US20040156840 A preferred IgM is autoantigen IgM, in particular anti-ds-DNA and anti-phospholipid IgM; may be mixed with an antiinflammatory agent, an immunosuppressive agent and/or a cytostatic agent |
| 08/12/2004 | US20040156834 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis |
| 08/12/2004 | US20040156830 Vector and pharmaceutical composition containing cell death inducing gene |
| 08/12/2004 | US20040156827 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 08/12/2004 | US20040156826 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 08/12/2004 | US20040156824 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 08/12/2004 | US20040156823 inner structures of the syringe are coated with an inductor and the syringe is filled with a body fluid, incubated and a therapeutically-effective protein, e.g., interleukin 1 receptor antagonist, interleukin-4, interleukin-10 and tumour necrosis factor receptor Type I or Type II is formed |
| 08/12/2004 | US20040156822 can be administered alone, or in combination with a colony stimulating factor or hemoregulatory agent |
| 08/12/2004 | US20040156787 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic theraphy and in vivo diagnostic |
| 08/12/2004 | DE4120345C5 Proteinfragmente aus dem mittleren Bereich des Flagellins von Borrelia burgdorferi, geeignet als Antigene zum spezifischen Antikörpernachweis sowie Verfahren zu ihrer Herstellung Protein fragments from the central region of the flagellin of Borrelia burgdorferi useful as antigens for the specific detection of antibodies as well as methods for their preparation |
| 08/12/2004 | DE10311106A1 Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper und ihre Verwendung Peptides against cold intolerance inducing autoantibodies and their use |
| 08/12/2004 | CA2514937A1 Paramyxoviral vectors encoding ribozymes and uses thereof |
| 08/12/2004 | CA2514653A1 Uses of integrin alphavbeta3 antagonists |
| 08/12/2004 | CA2514582A1 Amyloid-.beta.(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof |
| 08/12/2004 | CA2514536A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 08/12/2004 | CA2514517A1 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 08/12/2004 | CA2514474A1 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | CA2514417A1 Custom-made meganuclease and use thereof |
| 08/12/2004 | CA2514179A1 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 08/12/2004 | CA2514125A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2514117A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2514001A1 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/12/2004 | CA2513712A1 Osteogenic composition |
| 08/12/2004 | CA2513699A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | CA2513598A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | CA2512879A1 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| 08/12/2004 | CA2512808A1 Regulation of allergen induced gene |
| 08/12/2004 | CA2512169A1 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 08/12/2004 | CA2512161A1 Hyperthermia oncolysis co-therapy |
| 08/12/2004 | CA2511562A1 Hcv combination therapy |
| 08/12/2004 | CA2508340A1 Transcriptional activator |
| 08/12/2004 | CA2485568A1 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | CA2453809A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins, and biologically active substances and therapeutics produced therewith |
| 08/11/2004 | EP1445315A1 Human and mammalian stem cell-derived neuronal survival polypeptides |
| 08/11/2004 | EP1445314A1 Novel glutamic acid receptor and utilization thereof |
| 08/11/2004 | EP1445263A1 Human beta-secretase enzyme, inhibitors and their compositions and uses |
| 08/11/2004 | EP1445262A1 PEPTIDE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF |
| 08/11/2004 | EP1444995A1 FGF-2 derived proteins for the preparation of biomaterials or medical devices such as stents |
| 08/11/2004 | EP1444989A1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/11/2004 | EP1444988A1 Anticancer agents |
| 08/11/2004 | EP1444986A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/11/2004 | EP1444985A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 08/11/2004 | EP1444890A1 RS1 deficient transgenic animal and uses thereof |
| 08/11/2004 | EP1444516A2 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 08/11/2004 | EP1444366A2 Antisense modulation of creb expression |